<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-antibiotics-10-00092">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Qiao</surname>
    <given-names>J.X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Hua</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Price</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery of 4-aryl-7-hydroxyindoline-based P2Y
   <sub>1</sub> antagonists as novel antiplatelet agents
  </article-title>
  <source>J. Med. Chem.</source>
  <year>2014</year>
  <volume>57</volume>
  <fpage>6150</fpage>
  <lpage>6164</lpage>
  <pub-id pub-id-type="doi">10.1021/jm5006226</pub-id>
  <pub-id pub-id-type="pmid">24931384</pub-id>
 </element-citation>
</ref>
